Corinth Group in India: The Morepen Deal and Beyond

The Corinth Group's India operations include the documented Morepen Laboratories deal and reports from Indian companies approached for advance-fee financing.

The Morepen Laboratories Deal

Morepen Laboratories Ltd (BSE: 500288), a pharmaceutical company listed on the Bombay Stock Exchange, received a share allotment involving Corinth Group entities. Companies House filings for UK entities in the Three Tuns network reference Morepen share allotments. This appears to be one of the few documented deals involving Corinth entities and a publicly listed company [Morepen Laboratories filings, Companies House filings].

Indian Companies as Targets

Complainant reports indicate that Indian companies have been approached by Corinth Group representatives offering corporate financing, with the standard pattern of advance fees under term sheets. India represents a significant potential market for advance-fee schemes given the large number of mid-market companies seeking growth capital [Complainant reports].

Reporting in India

Indian victims should report to: (1) SEBI — if the entity claimed to offer regulated financial services; (2) Economic Offences Wing of the relevant state police; (3) Enforcement Directorate — for cross-border financial fraud; (4) CBI — Central Bureau of Investigation for serious economic offences.

Key Facts

• Morepen Laboratories (BSE: 500288) share allotment involving Corinth entities
• Indian mid-market companies targeted for advance-fee financing
• Report to SEBI, Economic Offences Wing, Enforcement Directorate
• Cross-border coordination with Swiss/UK authorities possible

Complaint Reports

People Involved

Related Entities

Related Investigations